Answers are grounded in this paper and cite their sources.
Introduction: Young people with psychosis are six times more likely to be tobacco smokers than their gender- and age-matched peers. Smoking is a major contributor to the 15-year reduced life expectancy among people experiencing severe mental illness (SMI). There is a lack of evidence-supported interventions for smoking cessation among young people with SMI. Material and Methods: The study comprised two phases and aimed to assess i) the prevalence of smoking among a community sample of young people with psychotic illness or at high risk of developing psychosis; ii) the proportion who engaged in the intervention; iii) the proportion who achieved smoking cessation; and iv) secondary smoking-related outcomes. In phase one, prevalence of smoking was assessed. In phase two, over a one-year period, individuals identified as smokers were invited to participate in a 12-week tailored smoking cessation intervention program that included pharmacological treatment, motivational interviewing and behavioural change techniques. Those unwilling to participate in a full intervention were offered a brief intervention. Participants of the full intervention were assessed at baseline and at week 12 endpoint on: daily cigarettes smoked (self-report), exhaled CO, nicotine dependence, readiness to quit and confidence to quit. Results: Phase one: smoking prevalence was 48.2% (53/110). Smokers were significantly more likely to be male (X2= 6.41 p=0.009). Phase two: 67.2% (41/61) eligible clients engaged in a smoking cessation intervention Effectiveness: 21 clients (34.4%) participated in a full intervention, of whom three (14.3%) received a brief intervention initially and converted to full intervention. 20 participants (32.8%) received a brief intervention only. Ten (47.6%) participants in the full intervention and five (25%) in the brief intervention dropped out. Six (28.6% of full intervention) reported smoking cessation verified by CO monitoring. Participants who completed the full intervention (n=9) reduced number of cigarettes smoked, nicotine dependence, and exhaled CO, while both readiness and confidence to quit increased. Pharmacotherapy was predominantly combination NRT (n=18; 85.7%), varenicline (4.8%), oral NRT only (4.8%) or none (4.8%). Conclusion: This pilot real-world study demonstrates that both screening for smoking and offering an effective smoking cessation intervention are achievable in youth experiencing or at risk of psychosis.
No takes yet. Share an insight, caveat, or question.
Curtis et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: